Aglaris Limited

Active09111674 Private limited company

Incorporated: 2 July 2014 (12 years)
Industry: Research and experimental development on biotechnology (72110)
Directors: 3-Gutinver, S.L.
Joaquin Velasco Plaza
Jose Antonio Castillo Gonzalez
all 7 directors
Owned by: CRB Bio II, FCR
Accounts type: Total exemption full
Region: Greater London
Address: 167-169 Great Portland Street Great Portland Street
5th Floor
London
W1W 5PF

Website & contact details

Website: aglaris.co.uk

Filing status

Accounts due: 30 September 2027
Last accounts: 31 December 2025
Conf. stmt due: 30 October 2027
Last conf. stmt: 16 October 2026

Charges

Total: 1
Outstanding: 1
Part satisfied: 0
Satisfied: 0

Officers 8 active

Officer details are public data from the Companies House register.

3-Gutinver, S.L.

Corporate Director · Appointed 22 March 2024

Velasco Plaza, Joaquin

Director · Appointed 19 May 2020

Spanish

Born June 1955 (71)

Castillo Gonzalez, Jose Antonio

Director · Appointed 25 April 2016

Spanish

Born June 1969 (57)

Bio Cell Global Investments S.L

Corporate Director · Appointed 25 April 2016

Santos Iglesias, Angel José

Director · Appointed 18 December 2015

Spanish

Born March 1959 (67)

Costa Ferrando, Miquel, Dr

Secretary · Appointed 22 September 2015

Horna Tomás, David, Dr

Director · Appointed 2 July 2014

Spanish

Born January 1981 (45)

Costa Ferrando, Miquel, Dr

Director · Appointed 2 July 2014

Spanish

Born November 1978

Officer history (5 former)

22 March 2024

Appointed 3-Gutinver, S.L. as Corporate Director

31 January 2023

Resigned Docksey, Steven John as Director

19 May 2020

Appointed Velasco Plaza, Joaquin as Director

19 May 2020

Resigned Cabello Albendea, Pablo as Director

17 July 2018

Resigned Canal Vega, Francisco as Director

17 July 2018

Appointed Docksey, Steven John as Director

25 April 2016

Appointed Canal Vega, Francisco as Director

25 April 2016

Appointed Castillo Gonzalez, Jose Antonio as Director

25 April 2016

Appointed Bio Cell Global Investments S.L as Corporate Director

25 April 2016

Resigned Dominguez, Manuel Fuertes as Director

18 December 2015

Appointed Santos Iglesias, Angel José as Director

18 December 2015

Appointed Cabello Albendea, Pablo as Director

22 September 2015

Appointed Dominguez, Manuel Fuertes as Director

22 September 2015

Appointed Costa Ferrando, Miquel, Dr as Secretary

22 September 2015

Resigned Flexible Directors Limited as Corporate Secretary

2 July 2014

Appointed Costa Ferrando, Miquel, Dr as Director

2 July 2014

Appointed Horna Tomás, David, Dr as Director

2 July 2014

Appointed Flexible Directors Limited as Corporate Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

CRB Bio II, FCR

Corporate entity · Notified 28 February 2019

Owns 25–50% of shares

Holds 25–50% of voting rights

Fondo De Capital Riesgo

Former controllers (2)

1 July 2018

Ceased David Horna Tomás — Owns 25–50% of shares

1 July 2018

Ceased Miquel Costa Ferrando — Owns 25–50% of shares

Financials

Balance sheet as at 31 December 2025 · total exemption full accounts

Net Assets: £4,449,307
Cash: £203,409
Employees: 1

Debt Ratio: 32%
Current Ratio: 1.4x

Trend

Net Assets

Balance sheet detail

	2025	2024	2023	2022	2021	2020	2019
Fixed Assets	£5,740,108	£5,704,623	£5,612,145	£5,391,389	£4,933,895	£4,298,348	£2,746,878
Current Assets	£819,409	£927,184	£343,007	£419,329	£492,569	£314,827	£223,703
Debtors	£616,000	£445,138	£329,398	£380,076	£302,099	£277,720	£159,649
Cash	£203,409	£479,669	£1,802	£27,446	£177,067	£27,191	£61,732
Creditors (< 1 year)	£603,322	£334,917	£975,591	£426,548	£155,101	£152,862	£384,424
Creditors (> 1 year)	£1,506,888	£932,231	£1,419,722	£1,402,271	£791,594	£2,901,106	£561,879
Net Current Assets	£216,087	£592,267	(£632,584)	(£7,219)	£337,468	£161,965	(£160,721)
Net Assets	£4,449,307	£5,364,659	£3,559,839	£3,981,899	£4,479,769	£1,559,207	£2,024,278
Shareholder Funds	£4,449,307	£5,364,659	£3,559,839	£3,981,899	£4,479,769	£1,559,207	£2,024,278